Yang Y, Tan L, Hu J, Li Y, et al. Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China. Dis Esophagus 2022 Jun 2. pii: 6596998. doi: 10.1093.
PMID: 35649396